Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-day vs 14-day PAMC for H. pylori Eradication
NCT02959255Phase 4Completed
- Sponsor
- ELPEN
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esomeprazole, amoxicillin, metronidazole and clarithromycin in Helicobacter pylori infection, sponsored by ELPEN. Primary endpoint: Helicobacter pylori eradication rate. Started Jan 2017; status: completed.
02
Drugs
esomeprazoleamoxicillinmetronidazoleclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02959255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02959255.